Generali Investments, Management Co LLC
Position in STOK — Stoke Therapeutics, Inc.
CIK 2043136
LJUBLJANA, 2A
Position in STOK
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,084,635
+$859,581 QoQ
Shares Held
33,149
+379.6% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#2
of 8 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Generali Investments, Management Co LLC holds $6,891,697 across 5 Biotechnology names. STOK ranks #3 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,926 | $2,446,891 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,000 | $2,279,760 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
This page
|
33,149 | $1,084,635 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,276 | $795,637 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
946 | $284,774 |
All Filings in STOK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,084,635 | 33,149 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $225,054 | 6,912 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $78,429 | 2,471 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $41,195 | 1,753 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||